Digest Network Come funziona
Network
/
Società
Ha
Non verificato

Halda Therapeutics

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaOncologiaSalute

6 comunicati stampa

Guarda tutti i comunicati
22/04/2025
Halda Therapeutics Announces Appointment of Eyal Attar, MD, as Chief Medical Officer
Fonte
Halda Therapeutics
Emittente
Business Wire
1.00
0
24/02/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Halda Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating HLD-0915 in Metastatic Castration-Resistant Prostate Cancer
Fonte
Halda Therapeutics
Emittente
Business Wire
1.00
0
07/01/2025
Eventi
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Halda Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Fonte
Halda Therapeutics
Emittente
Business Wire
1.00
0
01/10/2024
Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer
Fonte
Halda Therapeutics
Emittente
Business Wire
1.00
0
12/08/2024
Scienza
Finanza
Associazioni/Professionisti
Sanità
Biotecnologia
Farmaceutica
Salute
Oncologia
Industria
Halda Therapeutics Secures $126 Million Financing to Advance RIPTAC™ Cancer Therapies into the Clinic for Major Solid Tumors
Fonte
Halda Therapeutics
Emittente
Business Wire
1.00
0
07/08/2024
Biotecnologia
Farmaceutica
Salute
Oncologia
Industria
Halda Therapeutics Announces Publication in Cell Chemical Biology Demonstrating Proof-of-Mechanism and Pharmacology of RIPTAC™ Therapeutics for Precision Treatment of Cancer
Fonte
Halda Therapeutics
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0